Llwytho...
The challenge of modulating β-cell autoimmunity in type 1 diabetes
With the conceptual advance some four decades ago that type 1 diabetes (T1D) represents an autoimmune disease, hope emerged that immune-based therapies would quickly evolve as a means to prevent and reverse the disorder. However, despite dozens of clinical trials seeking to achieve that purpose, the...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Lancet Diabetes Endocrinol |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7322790/ https://ncbi.nlm.nih.gov/pubmed/30528099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-8587(18)30112-8 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|